Overview

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Purpose: A 28-day US study in patients with type 2 diabetes mellitus to assess the safety and tolerability as well as the effects of treatment with an investigational drug.
Phase:
Phase 2
Details
Lead Sponsor:
Incyte Corporation